Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for cell & gene therapies, today announced financial...
Stay updated with breaking news from Regarding Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for cell & gene therapies, today announced financial...
Performant Financial Corporation , a leading provider of healthcare payment integrity services, today reported the following financial results for its fourth quarter and full year ended December 31,...
Q3 Revenue of $328 million, up 19% year-over-year Q3 Elastic Cloud Revenue of $143 million, up 29% year-over-year ...
FREMONT, Calif., Feb. 28, 2024 -- Cytek® Biosciences, Inc. , a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2023....
Grew Fourth Quarter Revenue to $98.2 million Increased 2023 Total Revenue 22% to $361.1 million Conference Call and Webcast Today at 4:30 p.m. ET ...